Regulus Therapeutics Inc.

Q1 2024 13F Holders

Symbol
RGLS
CUSIP
75915K309
Type
Equity
Class
COM
Num filings
52
Total reported value, excl. options
$129 M
Manager Report Date Value ($000) Shares Option Type